|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CACNA1A-VSTM2B (FusionGDB2 ID:12336) |
Fusion Gene Summary for CACNA1A-VSTM2B |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CACNA1A-VSTM2B | Fusion gene ID: 12336 | Hgene | Tgene | Gene symbol | CACNA1A | VSTM2B | Gene ID | 773 | 342865 |
| Gene name | calcium voltage-gated channel subunit alpha1 A | V-set and transmembrane domain containing 2B | |
| Synonyms | APCA|BI|CACNL1A4|CAV2.1|EA2|EIEE42|FHM|HPCA|MHP|MHP1|SCA6 | - | |
| Cytomap | 19p13.13 | 19q12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | voltage-dependent P/Q-type calcium channel subunit alpha-1Abrain calcium channel 1brain calcium channel Icalcium channel, L type, alpha-1 polypeptidecalcium channel, voltage-dependent, P/Q type, alpha 1A subunitfetal brain Ca2+ voltage-gated channel | V-set and transmembrane domain-containing protein 2B | |
| Modification date | 20200329 | 20200313 | |
| UniProtAcc | O00555 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000592864, ENST00000360228, ENST00000573710, ENST00000574822, | ENST00000335523, | |
| Fusion gene scores | * DoF score | 14 X 14 X 3=588 | 9 X 4 X 6=216 |
| # samples | 14 | 11 | |
| ** MAII score | log2(14/588*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/216*10)=-0.973527788638809 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CACNA1A [Title/Abstract] AND VSTM2B [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CACNA1A(13734692)-VSTM2B(30054753), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CACNA1A | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 10753886 |
| Hgene | CACNA1A | GO:0008219 | cell death | 16595610 |
| Hgene | CACNA1A | GO:0050804 | modulation of chemical synaptic transmission | 23376566 |
| Hgene | CACNA1A | GO:0070588 | calcium ion transmembrane transport | 24836863|26716990 |
| Hgene | CACNA1A | GO:1904645 | response to amyloid-beta | 18216187|23376566 |
| Hgene | CACNA1A | GO:1904646 | cellular response to amyloid-beta | 21883149 |
| Fusion gene breakpoints across CACNA1A (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across VSTM2B (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | GBM | TCGA-41-3915-01A | CACNA1A | chr19 | 13734692 | - | VSTM2B | chr19 | 30054753 | + |
Top |
Fusion Gene ORF analysis for CACNA1A-VSTM2B |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000592864 | ENST00000335523 | CACNA1A | chr19 | 13734692 | - | VSTM2B | chr19 | 30054753 | + |
| intron-3CDS | ENST00000360228 | ENST00000335523 | CACNA1A | chr19 | 13734692 | - | VSTM2B | chr19 | 30054753 | + |
| intron-3CDS | ENST00000573710 | ENST00000335523 | CACNA1A | chr19 | 13734692 | - | VSTM2B | chr19 | 30054753 | + |
| intron-3CDS | ENST00000574822 | ENST00000335523 | CACNA1A | chr19 | 13734692 | - | VSTM2B | chr19 | 30054753 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CACNA1A-VSTM2B |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CACNA1A-VSTM2B |
| Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CACNA1A | . |
| FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1A gives rise to P and/or Q-type calcium currents. P/Q-type calcium channels belong to the 'high-voltage activated' (HVA) group and are specifically blocked by the spider omega-agatoxin-IVA (AC P54282) (By similarity). They are however insensitive to dihydropyridines (DHP). {ECO:0000250|UniProtKB:P54282, ECO:0000269|PubMed:10049321, ECO:0000269|PubMed:10753886, ECO:0000269|PubMed:11723274, ECO:0000269|PubMed:15293273, ECO:0000269|PubMed:19232643, ECO:0000269|PubMed:24836863, ECO:0000269|PubMed:26716990}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CACNA1A-VSTM2B |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for CACNA1A-VSTM2B |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CACNA1A-VSTM2B |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | CACNA1A | O00555 | DB00661 | Verapamil | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB00661 | Verapamil | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB00661 | Verapamil | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB00661 | Verapamil | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB00836 | Loperamide | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB00836 | Loperamide | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB00836 | Loperamide | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB00836 | Loperamide | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB06283 | Ziconotide | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB06283 | Ziconotide | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB06283 | Ziconotide | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB06283 | Ziconotide | Inhibitor | Small molecule | Approved |
| Hgene | CACNA1A | O00555 | DB13746 | Bioallethrin | Blocker | Small molecule | Approved|Experimental |
| Hgene | CACNA1A | O00555 | DB13746 | Bioallethrin | Blocker | Small molecule | Approved|Experimental |
| Hgene | CACNA1A | O00555 | DB13746 | Bioallethrin | Blocker | Small molecule | Approved|Experimental |
| Hgene | CACNA1A | O00555 | DB13746 | Bioallethrin | Blocker | Small molecule | Approved|Experimental |
| Hgene | CACNA1A | O00555 | DB01244 | Bepridil | Inhibitor | Small molecule | Approved|Withdrawn |
| Hgene | CACNA1A | O00555 | DB01244 | Bepridil | Inhibitor | Small molecule | Approved|Withdrawn |
| Hgene | CACNA1A | O00555 | DB01244 | Bepridil | Inhibitor | Small molecule | Approved|Withdrawn |
| Hgene | CACNA1A | O00555 | DB01244 | Bepridil | Inhibitor | Small molecule | Approved|Withdrawn |
Top |
Related Diseases for CACNA1A-VSTM2B |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CACNA1A | C1720416 | Episodic ataxia type 2 (disorder) | 21 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Hgene | CACNA1A | C1832884 | Hemiplegic migraine, familial type 1 | 15 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Hgene | CACNA1A | C0752124 | Spinocerebellar Ataxia Type 6 (disorder) | 12 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Hgene | CACNA1A | C4310716 | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42 | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Hgene | CACNA1A | C0014553 | Absence Epilepsy | 2 | CTD_human;GENOMICS_ENGLAND |
| Hgene | CACNA1A | C0087012 | Ataxia, Spinocerebellar | 2 | CTD_human |
| Hgene | CACNA1A | C0752120 | Spinocerebellar Ataxia Type 1 | 2 | CTD_human |
| Hgene | CACNA1A | C0752121 | Spinocerebellar Ataxia Type 2 | 2 | CTD_human |
| Hgene | CACNA1A | C0752122 | Spinocerebellar Ataxia Type 4 | 2 | CTD_human |
| Hgene | CACNA1A | C0752123 | Spinocerebellar Ataxia Type 5 | 2 | CTD_human |
| Hgene | CACNA1A | C0752125 | Spinocerebellar Ataxia Type 7 | 2 | CTD_human |
| Hgene | CACNA1A | C0001890 | Akinetic Petit Mal | 1 | CTD_human |
| Hgene | CACNA1A | C0004134 | Ataxia | 1 | CTD_human |
| Hgene | CACNA1A | C0005586 | Bipolar Disorder | 1 | PSYGENET |
| Hgene | CACNA1A | C0013421 | Dystonia | 1 | GENOMICS_ENGLAND |
| Hgene | CACNA1A | C0206368 | Exfoliation Syndrome | 1 | CTD_human |
| Hgene | CACNA1A | C0240991 | Ataxia, Sensory | 1 | CTD_human |
| Hgene | CACNA1A | C0270816 | epilepsy and migraine | 1 | GENOMICS_ENGLAND |
| Hgene | CACNA1A | C0278161 | Ataxia, Motor | 1 | CTD_human |
| Hgene | CACNA1A | C0338488 | Alternating hemiplegia of childhood | 1 | ORPHANET |
| Hgene | CACNA1A | C0427190 | Ataxia, Truncal | 1 | CTD_human |
| Hgene | CACNA1A | C0520966 | Abnormal coordination | 1 | CTD_human |
| Hgene | CACNA1A | C0543888 | Epileptic encephalopathy | 1 | GENOMICS_ENGLAND |
| Hgene | CACNA1A | C0750937 | Ataxia, Appendicular | 1 | CTD_human |
| Hgene | CACNA1A | C0750940 | Tremor, Rubral | 1 | CTD_human |
| Hgene | CACNA1A | C0751124 | Epilepsy, Absence, Atypical | 1 | CTD_human |
| Hgene | CACNA1A | C3494934 | Benign paroxysmal torticollis of infancy | 1 | ORPHANET |
| Hgene | CACNA1A | C4281785 | Childhood Absence Epilepsy | 1 | CTD_human |
| Hgene | CACNA1A | C4317339 | Juvenile Absence Epilepsy | 1 | CTD_human |
| Hgene | CACNA1A | C4552765 | Epilepsy, Minor | 1 | CTD_human |
| Hgene | CACNA1A | C4553705 | Absence Seizure Disorder | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies